Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
22.39
+0.17 (0.77%)
At close: Sep 26, 2025, 4:00 PM EDT
22.37
-0.02 (-0.09%)
After-hours: Sep 26, 2025, 4:43 PM EDT
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $2.83 billion as of September 26, 2025. Its market cap has decreased by -39.52% in one year.
Market Cap
2.83B
Enterprise Value
2.92B
1-Year Change
-39.52%
Ranking
Category
Stock Price
$22.39
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $2.83B, an increase of 308.80%. That is a compound annual growth rate of 19.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 2.83B | -28.83% |
| Dec 31, 2024 | 3.97B | -44.04% |
| Dec 29, 2023 | 7.09B | 24.06% |
| Dec 30, 2022 | 5.72B | 24.22% |
| Dec 31, 2021 | 4.60B | 6.25% |
| Dec 31, 2020 | 4.33B | 121.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 646.08B |
| Johnson & Johnson | 432.01B |
| AbbVie | 387.42B |
| UnitedHealth Group | 312.04B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.77B |
| AstraZeneca | 226.78B |